NeuroFlow is a Healthtech company based in Philadelphia. It has raised $29M in total funding. Latest round: Series C. Backed by Magellan Health.
NeuroFlow funding overview
NeuroFlow is a Healthtech company based in Philadelphia. NeuroFlow has raised $29M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in March 2022. The round record for NeuroFlow runs through 2022; nothing later has been disclosed. Investors on record include Magellan Health.
NeuroFlow at a glance
Total raised
$29M
Latest round
Series C
Latest round date
March 2022
Industry
Healthtech
Headquarters
Philadelphia
Notable investors
Magellan Health
Frequently asked about NeuroFlow funding
How much has NeuroFlow raised?
NeuroFlow has raised $29M in total disclosed funding across the rounds on record.
Who has invested in NeuroFlow?
Magellan Health are named among the investors backing NeuroFlow.
What was the latest NeuroFlow funding round?
The most recent disclosed round is a Series C, announced in March 2022.
Where is NeuroFlow based?
NeuroFlow is based in Philadelphia.
What sector does NeuroFlow operate in?
NeuroFlow is tracked under Healthtech from Philadelphia, with $29M in disclosed funding.
When did NeuroFlow last raise?
The last disclosed NeuroFlow round closed in March 2022 at Series C.
We update the NeuroFlow record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Healthtech companies in Philadelphia and their backers are listed below.
